LavaTM Liquid Embolic System
LavaTM Liquid Embolic System consists of a liquid embolic agent, dimethyl sulfoxide(DMSO) and Syringes.
Liquid Embolic Agent：1 * 1.5 mL / vial
DMSO：1.5mL
Syringes：3 * 1 mL
Specifications：LAVA-12, LAVA-18, LAVA-34.
- Non-adhesive material
Non-stick catheter, it is more safe；
- Unique low-viscosity formula Lava-12, comprehensive degrees of viscosity;
LAVA-12、LAVA-18和LAVA-34；
- better dispersion and penetration
deeper penetration and dispersion into the nidus & distal microvessels;
More micronized grain size of Tantalum powder, the precipitation is slower, the visibility is excellent.
Intended Use for LavaTM Liquid Embolic System
arteriovenous malformation（AVM）
hypervascular tumors
It is indicated for the embolization of lesions in the peripheral and neurovasculature, including arteriovenous malformations (AVM) and hypervascular tumors.
New possible indication : DAVF, Csdh,PVE, VC.
Intended Use for LavaTM Liquid Embolic System
Prior treatment
Post treatment
AVMEmbolization of Brain Arteriovenous Malformation (AVM)
Lava can also be used for endovascular embolization of cardiac and peripheral (pulmonary, renal) arteriovenous fistulas.
LavaTM Liquid Embolic System - Comparison with Squid
LavaTM Liquid Embolic System-Video
LAVA has the overall continuity and permeability of onyx, as well as the good dispersion of GLUBRAN2
Injection images after standing for 1.5 hours
The distal end has been embolized, and the proximal end is injected with Lava34 image